propranolol glucuronide has been researched along with cimetidine in 1 studies
*Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. [MeSH]
*Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. [MeSH]
Studies (propranolol glucuronide) | Trials (propranolol glucuronide) | Recent Studies (post-2010) (propranolol glucuronide) | Studies (cimetidine) | Trials (cimetidine) | Recent Studies (post-2010) (cimetidine) |
---|---|---|---|---|---|
16 | 2 | 0 | 9,473 | 1,687 | 377 |
Protein | Taxonomy | propranolol glucuronide (IC50) | cimetidine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.59 | |
Solute carrier family 22 member 2 | Mus musculus (house mouse) | 8 | |
Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.82 | |
Histamine H2 receptor | Homo sapiens (human) | 1.1742 | |
Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 1.02 | |
Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.82 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.0333 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebihara, A; Fujimura, A; Ohashi, K; Tateishi, T | 1 |
1 trial(s) available for propranolol glucuronide and cimetidine
Article | Year |
---|---|
The influence of diltiazem versus cimetidine on propranolol metabolism.
Topics: Adult; Chromatography, High Pressure Liquid; Cimetidine; Diltiazem; Half-Life; Humans; Lactates; Male; Premedication; Propranolol | 1992 |